A Phase 1 Study of Pevonedistat: A NEDD8-Activating Enzyme Inhibitor in Combination with Temozolomide and Irinotecan in Pediatric Patients with Recurrent or Refractory Solid or Central Nervous System Tumors |
02/24/2022 - 8:00am to 9:00am CST |
Defining the Role of Chromatin Structure in the Evolution from Transient Abnormal Myelopoiesis to Acute Megakaryoblastic Leukemia |
06/23/2022 - 8:00am to 9:00am CDT |
Disrupting cMET-HGF Axis in Sarcoma to Improve HER2-targeted CAR T-cell Therapy/Protein Markers of Acute Myeloid Leukemia Subclones that Expand at Relapse: Investigation with Clinical Applications |
06/16/2022 - 8:00am to 9:00am CDT |
Dissecting the Sickle Cell Disease Phenotype through International Collaborative Research Studies |
10/21/2021 - 8:00am to 9:00am CDT |
Evaluating the Effects of Critical Metabolite Depletion in Rhabdomyosarcoma |
04/21/2022 - 8:00am to 9:00am CDT |
Evolution of Germline Cancer Genomics: From Rare Disorders to Precision Oncology Trials |
05/12/2022 - 8:00am to 9:00am CDT |
Human Trafficking 101: A Healthcare Primer |
01/13/2022 - 8:00am to 9:00am CST |
Immune Thrombocytopenia: The Never-Ending Enigma |
01/27/2022 - 8:00am to 9:00am CST |
Improving Outcomes in Pediatric Leukemia with Big Data |
01/06/2022 - 8:00am to 9:00am CST |
Inflammatory Caspases and Sickle Cell Disease |
09/23/2021 - 8:00am to 9:00am CDT |